Xylyx Bio has received U.S. Food and Drug Administration Orphan Drug Designation for Inspirex Lung and a $2.99 million National Institutes of Health grant to advance development of the investigational …
Lung Transplantation
Xylyx Bio has received U.S. Food and Drug Administration Orphan Drug Designation for Inspirex Lung and a $2.99 million National Institutes of Health grant to advance development of the investigational …
CARY, N.C., Jan. 21, 2026 /PRNewswire/ — Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument (also known as WELL-101), a novel …
Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.
Copyright ©️ 2026 Daily Transplant News | All rights reserved.